questionsmedicales.fr
Tumeurs
Tumeurs par siège
Tumeurs du thorax
Tumeurs du thorax : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Tumeurs thoraciques
Biopsie
Imagerie médicale
Tomodensitométrie
IRM
Bronchoscopie
Marqueurs tumoraux
Tumeurs thoraciques
Suivi médical
Histologie
Tumeurs thoraciques
Diagnostic
Tests génétiques
Tumeurs thoraciques
Traitement ciblé
Symptômes
5
Symptômes
Tumeurs thoraciques
Essoufflement
Perte de poids
Tumeurs thoraciques
Symptômes
Hémoptysie
Tumeurs thoraciques
Symptômes
Fatigue
Tumeurs thoraciques
Symptômes
Types de tumeurs
Tumeurs thoraciques
Symptômes
Prévention
5
Prévention
Tabagisme
Agents cancérigènes
Dépistage
Tumeurs thoraciques
Prévention
Alimentation
Prévention
Tumeurs thoraciques
Exercice physique
Prévention
Tumeurs thoraciques
Vaccination
Prévention
Cancers
Traitements
5
Chirurgie
Chimiothérapie
Radiothérapie
Chirurgie
Tumeurs thoraciques
Stade de la maladie
Chimiothérapie
Tumeurs thoraciques
Traitement néoadjuvant
Radiothérapie
Tumeurs thoraciques
Traitement complémentaire
Thérapies ciblées
Tumeurs thoraciques
Traitement
Complications
5
Complications
Métastase
Insuffisance respiratoire
Douleur thoracique
Tumeurs thoraciques
Complications
Difficultés respiratoires
Tumeurs thoraciques
Complications
Thrombose
Tumeurs thoraciques
Complications
Complications post-chirurgicales
Tumeurs thoraciques
Chirurgie
Facteurs de risque
5
Facteurs de risque
Tabagisme
Amiante
Âge
Facteurs de risque
Tumeurs thoraciques
Antécédents médicaux
Facteurs de risque
Tumeurs thoraciques
Exposition professionnelle
Facteurs de risque
Tumeurs thoraciques
Mode de vie
Facteurs de risque
Tumeurs thoraciques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Tumeurs du thorax : Questions médicales les plus fréquentes",
"headline": "Tumeurs du thorax : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Tumeurs du thorax : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-21",
"dateModified": "2025-03-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Tumeurs du thorax"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Tumeurs par siège",
"url": "https://questionsmedicales.fr/mesh/D009371",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs par siège",
"code": {
"@type": "MedicalCode",
"code": "D009371",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.588"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Adénocarcinome pulmonaire",
"alternateName": "Adenocarcinoma of Lung",
"url": "https://questionsmedicales.fr/mesh/D000077192",
"about": {
"@type": "MedicalCondition",
"name": "Adénocarcinome pulmonaire",
"code": {
"@type": "MedicalCode",
"code": "D000077192",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.588.894.797.520.055"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Adénocarcinome bronchioloalvéolaire",
"alternateName": "Adenocarcinoma, Bronchiolo-Alveolar",
"url": "https://questionsmedicales.fr/mesh/D002282",
"about": {
"@type": "MedicalCondition",
"name": "Adénocarcinome bronchioloalvéolaire",
"code": {
"@type": "MedicalCode",
"code": "D002282",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.588.894.797.520.055.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Blastome pulmonaire",
"alternateName": "Pulmonary Blastoma",
"url": "https://questionsmedicales.fr/mesh/D018202",
"about": {
"@type": "MedicalCondition",
"name": "Blastome pulmonaire",
"code": {
"@type": "MedicalCode",
"code": "D018202",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.588.894.797.520.867"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tumeurs fibreuses solitaires de la plèvre",
"alternateName": "Solitary Fibrous Tumor, Pleural",
"url": "https://questionsmedicales.fr/mesh/D054363",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs fibreuses solitaires de la plèvre",
"code": {
"@type": "MedicalCode",
"code": "D054363",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.588.894.797.640.800"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs du thorax",
"alternateName": "Thoracic Neoplasms",
"code": {
"@type": "MedicalCode",
"code": "D013899",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yan Wang",
"url": "https://questionsmedicales.fr/author/Yan%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China."
}
},
{
"@type": "Person",
"name": "Naseema Gangat",
"url": "https://questionsmedicales.fr/author/Naseema%20Gangat",
"affiliation": {
"@type": "Organization",
"name": "Mayo Clinic, Rochester, MN, USA."
}
},
{
"@type": "Person",
"name": "Anja C Roden",
"url": "https://questionsmedicales.fr/author/Anja%20C%20Roden",
"affiliation": {
"@type": "Organization",
"name": "Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, MN."
}
},
{
"@type": "Person",
"name": "Marianne Pavel",
"url": "https://questionsmedicales.fr/author/Marianne%20Pavel",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, University Hospital Erlangen, Erlangen, Germany."
}
},
{
"@type": "Person",
"name": "Dermot O'Toole",
"url": "https://questionsmedicales.fr/author/Dermot%20O%27Toole",
"affiliation": {
"@type": "Organization",
"name": "Department of Gastroenterology, St. Vincent's University Hospital and St James's Hospital, And Trinity College Dublin, The University of Dublin, Dublin, Ireland."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Impact of Nonthermal Plasma on Lipid Oxidation from the Perspective of Plasma Treatment Parameters and Plasma Species: Identification of Key Reactive Species.",
"datePublished": "2023-09-18",
"url": "https://questionsmedicales.fr/article/37723886",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.jafc.3c03706"
}
},
{
"@type": "ScholarlyArticle",
"name": "Performance evaluation of the Aptima CMV quant assay using plasma and non-plasma samples.",
"datePublished": "2023-04-23",
"url": "https://questionsmedicales.fr/article/37126896",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jcv.2023.105467"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison of safety and efficacy of convalescent plasma with fresh frozen plasma in severe covid-19 patients.",
"datePublished": "2022-09-09",
"url": "https://questionsmedicales.fr/article/36102392",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/0001-3765202220210202"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinical Benefits of Early Concurrent Use of Cryoprecipitate and Plasma Compared With Plasma Only in Bleeding Trauma Patients.",
"datePublished": "2022-07-17",
"url": "https://questionsmedicales.fr/article/35759689",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/CCM.0000000000005596"
}
},
{
"@type": "ScholarlyArticle",
"name": "Plasma collection and supply in Europe: Proceedings of an International Plasma and Fractionation Association and European Blood Alliance symposium.",
"datePublished": "2023-07-18",
"url": "https://questionsmedicales.fr/article/37463772",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/vox.13491"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Tumeurs",
"item": "https://questionsmedicales.fr/mesh/D009369"
},
{
"@type": "ListItem",
"position": 3,
"name": "Tumeurs par siège",
"item": "https://questionsmedicales.fr/mesh/D009371"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tumeurs du thorax",
"item": "https://questionsmedicales.fr/mesh/D013899"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Tumeurs du thorax - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Tumeurs du thorax",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Tumeurs du thorax",
"description": "Comment diagnostiquer une tumeur thoracique ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels marqueurs tumoraux sont associés aux tumeurs thoraciques ?\nQuelle est l'importance de l'histologie ?\nLes examens génétiques sont-ils utiles ?",
"url": "https://questionsmedicales.fr/mesh/D013899?mesh_terms=Plasma#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Tumeurs du thorax",
"description": "Quels sont les symptômes courants des tumeurs thoraciques ?\nLa perte de poids est-elle un symptôme ?\nLes tumeurs thoraciques causent-elles des saignements ?\nComment la fatigue se manifeste-t-elle ?\nLes symptômes varient-ils selon le type de tumeur ?",
"url": "https://questionsmedicales.fr/mesh/D013899?mesh_terms=Plasma#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Tumeurs du thorax",
"description": "Comment prévenir les tumeurs thoraciques ?\nLe dépistage est-il utile ?\nL'alimentation joue-t-elle un rôle ?\nL'exercice physique aide-t-il à prévenir ?\nLes vaccinations sont-elles importantes ?",
"url": "https://questionsmedicales.fr/mesh/D013899?mesh_terms=Plasma#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Tumeurs du thorax",
"description": "Quels traitements sont disponibles pour les tumeurs thoraciques ?\nLa chirurgie est-elle toujours nécessaire ?\nQu'est-ce que la chimiothérapie néoadjuvante ?\nLa radiothérapie est-elle efficace ?\nY a-t-il des traitements ciblés disponibles ?",
"url": "https://questionsmedicales.fr/mesh/D013899?mesh_terms=Plasma#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Tumeurs du thorax",
"description": "Quelles complications peuvent survenir ?\nLes tumeurs thoraciques peuvent-elles causer des douleurs ?\nComment les tumeurs affectent-elles la respiration ?\nLes tumeurs peuvent-elles provoquer des caillots sanguins ?\nQuelles sont les complications post-chirurgicales ?",
"url": "https://questionsmedicales.fr/mesh/D013899?mesh_terms=Plasma#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Tumeurs du thorax",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes antécédents médicaux jouent-ils un rôle ?\nL'exposition professionnelle est-elle un facteur ?\nLe mode de vie influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D013899?mesh_terms=Plasma#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une tumeur thoracique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par imagerie (radiographie, scanner) et biopsie."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent la tomodensitométrie, l'IRM et la bronchoscopie."
}
},
{
"@type": "Question",
"name": "Quels marqueurs tumoraux sont associés aux tumeurs thoraciques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les marqueurs comme le CEA et le CA 125 peuvent être utilisés pour le suivi."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'histologie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'histologie permet de déterminer le type de tumeur et son agressivité."
}
},
{
"@type": "Question",
"name": "Les examens génétiques sont-ils utiles ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils aident à identifier des mutations spécifiques pour le traitement ciblé."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des tumeurs thoraciques ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent la toux persistante, la douleur thoracique et l'essoufflement."
}
},
{
"@type": "Question",
"name": "La perte de poids est-elle un symptôme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la perte de poids inexpliquée peut être un signe de tumeur thoracique."
}
},
{
"@type": "Question",
"name": "Les tumeurs thoraciques causent-elles des saignements ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent provoquer des hémoptysies, c'est-à-dire des saignements dans les voies respiratoires."
}
},
{
"@type": "Question",
"name": "Comment la fatigue se manifeste-t-elle ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "La fatigue peut être persistante et s'aggraver avec l'évolution de la maladie."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de tumeur ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon le type et la localisation de la tumeur."
}
},
{
"@type": "Question",
"name": "Comment prévenir les tumeurs thoraciques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabagisme et l'exposition à des agents cancérigènes aide à prévenir."
}
},
{
"@type": "Question",
"name": "Le dépistage est-il utile ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage précoce peut aider à détecter les tumeurs à un stade précoce."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut réduire le risque de développer des tumeurs."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il à prévenir ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut contribuer à réduire le risque de cancer."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations, comme contre le HPV, peuvent réduire le risque de cancers associés."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les tumeurs thoraciques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chirurgie, la chimiothérapie et la radiothérapie."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle toujours nécessaire ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la chirurgie dépend du stade et de la localisation de la tumeur."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que la chimiothérapie néoadjuvante ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est un traitement administré avant la chirurgie pour réduire la taille de la tumeur."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle efficace ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est souvent utilisée pour traiter les tumeurs non opérables ou en complément."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements ciblés disponibles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des thérapies ciblées sont disponibles pour certains types de tumeurs spécifiques."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la métastase, l'infection et l'insuffisance respiratoire."
}
},
{
"@type": "Question",
"name": "Les tumeurs thoraciques peuvent-elles causer des douleurs ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent provoquer des douleurs thoraciques dues à la pression sur les nerfs."
}
},
{
"@type": "Question",
"name": "Comment les tumeurs affectent-elles la respiration ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent obstruer les voies respiratoires, entraînant des difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Les tumeurs peuvent-elles provoquer des caillots sanguins ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent augmenter le risque de thrombose veineuse profonde."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications post-chirurgicales ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des infections, des saignements et des problèmes respiratoires."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme, l'exposition à l'amiante et les antécédents familiaux sont des facteurs clés."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de tumeurs thoraciques augmente avec l'âge."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de cancer augmentent le risque de développer des tumeurs thoraciques."
}
},
{
"@type": "Question",
"name": "L'exposition professionnelle est-elle un facteur ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines professions exposent à des substances cancérigènes, augmentant le risque."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 18/03/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Publications dans "Tumeurs du thorax" :
3 publications dans cette catégorie
Affiliations :
Mayo Clinic, Rochester, MN, USA.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, MN.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, University Hospital Erlangen, Erlangen, Germany.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Gastroenterology, St. Vincent's University Hospital and St James's Hospital, And Trinity College Dublin, The University of Dublin, Dublin, Ireland.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Division of Pancreatic Surgery, Pancreas Translational & Clinical Research Center, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
University of Milan, Department of Health Sciences and S.C. Anatomia Patologica, ASST Santi Paolo e Carlo, Milan, Italy.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Institute of Pathology, University of Cologne, Cologne, Germany.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Texas Tech University Health Sciences Center, El Paso, TX, USA.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
CRIMM-Centro Ricerca e Innovazione delle Malattie Mieloproliferative, Azienda Ospedaliera-Universitaria Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Mayo Clinic, Rochester, MN, USA.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
University Clinic Wuppertal, University of Witten/Herdecke, Wuppertal, Germany. hm.kvasnicka@patho-uwh.de.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Institute of Pathology, University Medical Center Mainz, JGU-Mainz, Mainz 55131, Germany.
Joint Unit Immunopathology, Institute of Pathology, University Medical Center, JGU-Mainz and TRON, Translational Oncology at the University Medical Center, JGU-Mainz, Mainz 55131, Germany.
Institute of Pathology, Heidelberg University Hospital, Heidelberg 69120, Germany.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Haematology, Queen's University, Belfast, United Kingdom.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Erzincan Binali Yildirim University, Mengucek Gazi Training and Research Hospital, Erzincan, Turkey.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Erzincan Binali Yildirim University, Mengucek Gazi Training and Research Hospital, Erzincan, Turkey.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Eskisehir City Hospital, Eskisehir, Turkey.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Erzincan Binali Yildirim University, Mengucek Gazi Training and Research Hospital, Erzincan, Turkey.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Erzincan Binali Yildirim University, Mengucek Gazi Training and Research Hospital, Erzincan, Turkey.
Publications dans "Tumeurs du thorax" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Erzincan Binali Yildirim University, Mengucek Gazi Training and Research Hospital, Erzincan, Turkey.
Publications dans "Tumeurs du thorax" :
Nonthermal plasma is a mild processing technology for food preservation. Its impact on lipid oxidation was investigated in this study. Stripped methylesters were considered as a basic lipid model syst...
Cytomegalovirus (CMV) infection has a major negative impact on transplantation and is associated with increased morbidity and mortality in this patient population. Quantitation of CMV infections using...
The analytical performance of the assay was assessed using commercially available CMV reference panels that meet the 1st WHO International Standard for Human Cytomegalovirus for nucleic acid amplifica...
The 95% LOD of the Aptima assay was determined to be 50 IU/mL and 200 IU/mL for the MGB CMV assay. A strong linear correlation with the reference panel (R...
The Aptima CMV assay is both sensitive and accurate in quantifying CMV in both plasma and non-plasma specimens on the fully automated Panther system....
Role of Convalescent plasma (COPLA) to treat severe COVID-19 is under investigation. We compared efficacy and safety of COPLA with fresh frozen plasma (FFP) in severe COVID-19 patients....
One group received COPLA with standard medical care (n = 14), and another group received random donor FFP, as control with standard medical care (n = 15) in severe COVID-19 disease....
The proportion of patients free of ventilation at day seven were 78.5% in COPLA group, and 93.3 % in control group were not significant (p= 0.258). However, improved respiratory rate, O2 saturation, S...
The effectiveness of cryoprecipitate (Cryo) in trauma has not been well established; the benefits of Cryo might have been overestimated in previous studies since the difference in the total amount of ...
Retrospective cohort study....
The American College of Surgeons Trauma Quality Improvement Program database between 2015 and 2019....
Patients who received greater than or equal to 5 units of packed RBCs and at least 1 unit of FFP within the first 4 hours after arrival to a hospital were included and dichotomized according to whethe...
None....
The outcomes of patients treated with Cryo and FFP were compared with those treated with FFP only using propensity score-matching analysis. The dose of administered clotting factors in each group was ...
Cryo use combined with FFP was significantly associated with reduced mortality in bleeding trauma patients. Future randomized controlled trials are warranted to confirm these results....
At the symposium organized by the International Plasma and Fractionation Association and European Blood Alliance, experts presented their views and experiences showing that the public sector and its b...
A biochemical way to measure seizures would greatly benefit epilepsy research and clinical follow-up. Short-term biomarkers like lactate exist, and interest in biomarkers representative of longer-term...
A proteomic analysis was performed on plasma samples of 120 persons with seizures using the Olink Neuro-exploratory panel. Participants were selected from a regional biobank study in Västra Götaland (...
We identified significant differences in protein levels between the recent seizure and seizure-free patient groups for Cadherin-15 [(CDH15; p = 0.008)], Latent transforming growth factor beta-binding ...
The findings in this study present CDH15, LTBP3, PHOSPHO1 and PAEP as candidate markers of seizure activity. Further confirmatory studies are needed....
To address a national concern over the sufficiency of plasma, Canadian Blood Services (CBS) initiated a proof-of-concept programme with three new source plasma collection centres, aiming to demonstrat...
One-hundred and one qualitative interviews with source plasma donors in three new source plasma centres in Canada were carried out....
CBS played a critical role in motivating whole-blood donors to switch to plasma donation by building on their identity as a donor and facilitating access. Community was central to ensuring that donors...
Campaigns to convert existing blood donors to plasma donors should build on their identity as a donor and structure the centre as a safe and welcoming place. To retain donors, blood collection agencie...
As the first step of metabolomic analysis in biomarker identification studies, various types of blood collection tubes are used in clinical practice. However, little attention is paid to potential con...
Pregnancy at advanced maternal age (AMA) is a condition of potential risk for the development of maternal-fetal complications with possible repercussions even in the long term. Here, we analyzed the c...
From producing individual blood components for transfusion to the removal of pathogenic substances, apheresis is a cornerstone of modern medical therapies. The use of therapeutic plasma exchange (TPE)...